Breaking News

Zydus LifeSciences Acquires Biologics Manufacturing Facilities from Agenus

Establishes Zylidac Bio, a dedicated U.S.-based CDMO.

Author Image

By: Charlie Sternberg

Associate Editor

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has closed its acquisition of Agenus Inc.’s biologics manufacturing facilities. All acquired manufacturing assets and operations will be housed under a newly formed, dedicated U.S. based CDMO named Zylidac Bio LLC. This acquisition provides Zydus immediate access to advanced biologics manufacturing capabilities and establishes a key presence in California, a leading global biotechnology hub....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters